Breast cancer (BC) displays striking genetic, epigenetic and phenotypic diversity. N6 -methyladenosine (m6A) in mRNA has emerged as a crucial epitranscriptomic modification that controls cancer self-renewal and cell fate. However, the key enzymes of m6A expression and function in human breast carcinogenesis remain unclear. | Changes of N6-methyladenosine modulators promote breast cancer progression